The Consultation Experience at Allen Medical Aesthetics

For our patients seeking advanced aesthetic injectables or regenerative treatments like Platelet-Rich Plasma (PRP) Joint Injections and Stemwave therapy, precision is paramount. To ensure the highest level of safety, accuracy, and efficacy, we utilize the Clarius High-Definition Wireless Ultrasound, powered by advanced Clarius Intelligence AI.

The Clarius system features high-frequency imaging that reveals the intricate, living layers of your facial and musculoskeletal anatomy in real time. This advanced artificial intelligence allows our medical team to visualize the exact depth and condition of tissue structures before, during, and after treatment, transforming aesthetic and regenerative care from an art of estimation into a science of precision.

Facial anatomy is highly individualized: vessels deviate, fat compartments shift, and muscle planes vary. We utilize high-frequency ultrasound to map your facial vascular network, identifying the precise location and depth of critical arteries and veins. This proactive vascular mapping significantly reduces the risk of intravascular injection and vascular occlusion, the most severe complication associated with dermal fillers, and allows us to visually confirm the precise placement of filler within the targeted tissue plane.

Traditional "blind" joint injections rely on anatomical landmarks and practitioner feel, which can lead to variable accuracy. Clinical studies demonstrate that ultrasound-guided injections increase accuracy to over 95%, ensuring that regenerative therapies like PRP are delivered precisely to the targeted injured tissues. Combined with Stemwave therapy, Clarius imaging allows us to map the depth and location of tissue damage and target the energy delivery with exact precision to the compromised tissue.

For our patients pursuing medical weight loss, hormone replacement therapy (BHRT), or body contouring, the number on a traditional scale is an inadequate measure of health. To provide a truly comprehensive metabolic assessment, we utilize the InBody Body Composition Analyzer.

InBody employs Direct Segmental Multi-frequency Bioelectrical Impedance Analysis (DSM-BIA) to measure your body composition across five distinct segments (each limb and the trunk) independently. Validated in over 8,000 clinical studies, this technology does not rely on empirical estimations based on age or gender; it provides an exact, individualized measurement of your unique physiology.

This level of detail is particularly critical for patients utilizing GLP-1 receptor agonists for medical weight loss. Clinical research indicates that while GLP-1 therapies are highly effective for fat reduction, they can also lead to unintended decreases in skeletal muscle mass if not properly managed.

The InBody device allows our medical team to closely monitor your fat-to-muscle ratio, ensuring that your weight loss is coming from adipose tissue rather than metabolically active lean muscle. Furthermore, the InBody system precisely measures visceral fat, the deep abdominal fat that surrounds internal organs and is strongly linked to metabolic disease risk.